Nuked 
Hello, tech enthusiasts! Welcome to an exciting dive into the world of cutting-edge technology that is reshaping lives.
The startup Phantom Neuro has made headlines by securing a whopping $19 million in funding to advance its groundbreaking device. This wristband-like technology promises to assist amputees in controlling their prosthetic limbs effortlessly.
Phantom Neuro isn’t just any startup; it stands at the forefront of neurotechnology. It has already achieved significant milestones, including two crucial FDA designations—a breakthrough device status and a TAP designation, aiding its journey toward commercialization.
At the heart of its innovation is a deep understanding of phantom limbs, which explains why amputees often feel sensations in limbs that are no longer there. The company has developed “Phantom X” software, which accurately interprets nerve impulses and translates them into precise movements for prosthetics.
In a recent study, the technology demonstrated a remarkable 94% accuracy in processing movements, and once implanted, accuracy is expected to soar even higher. Users can regain up to 85% of functionality with just a quick calibration session!
Leading the charge as a strategic investor is Ottobock, a major player in prosthetics. Joining them are both returning and new investors eager to support this innovative journey, with previous backers including well-known venture firms and even Johns Hopkins and Intel.
This ambitious project originated from the vision of Dr. Connor Glass, whose early aspirations of military service shifted toward neurosurgery after a series of personal challenges. His focus on widespread impact and the evolving landscape of brain-computer interfaces galvanized him to explore the potential of nerve endings.
Phantom Neuro envisions its technology primarily aiding prosthetic arms, with plans to extend its reach to legs and possibly even robotic controls in the future. The intersection of technology and humanity continues to expand, as Phantom strives to bridge that gap.
